2m 2m 2m 2m 2m 2m 2m
NOVAVAX (NVAX)
NASDAQ
$10.45-$0.15 (-1.46%)
Price as of Oct 02, 2026 5:34 PM EDT- $1.7BMarket Cap
- 10.99%1-Year Change
- BiotechnologyIndustry
NOVAVAX (NVAX)
$10.45-$0.15 (-1.46%)
NVAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.60 | ||
Change | -$0.21 (-1.94%) | ||
Open | $10.75 | ||
High | $10.98 | ||
Low | $10.54 | ||
Previous Close | $10.81 | ||
Volume | 3,149,723 | ||
30-Day Average Volume | 5,512,771 | ||
1-Week Change | 0.00% | ||
1-Month Change | 4.74% | ||
1-Year Change | 10.99% | ||
3-Year Change | 46.41% | ||
5-Year Change | -94.16% | ||
Fundamentals | |||
Shares Outstanding | 164.9M | ||
Total Assets | $955.6M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $18.9M | ||
Net Income | -$53.4M | ||
Free Cash Flow | -$73.4M | ||
EBIT | -$47.1M | ||
EBITDA | -$44.1M | ||
Net Working Capital | $440.5M | ||
EPS | -$0.32 | ||
Enterprise Value/EBITDA | -42 | ||
Enterprise Value/Revenue | 98 | ||
P/B | -9 | ||
P/E | -33 | ||
PEG | 0 | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/13/2007 | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 05/10/2019 | ||
Earnings & Revenue